Rumours have become the currency of Westminster, but one story continues to gather momentum. Credible political sources suggest Wes Streeting could return as Secretary of State for Health and Social Care. Whether that proves to be the case remains to be seen. If it does, the NHS may gain something it has lacked for much of the past decade: continuity. In a service where ministerial turnover has become almost routine, stability itself has become a strategic advantage.

Streeting's first tenure was defined by ambition but also by distraction. Few would question his appetite for reform. He consistently challenged entrenched thinking around NHS productivity, digital transformation, prevention and accountability. Yet his period in office coincided with significant political turbulence. Some commentators argued that senior Cabinet figures, including Streeting, were heavily engaged in the internal politics that ultimately led to the departure of the Prime Minister. Others dispute that interpretation. Regardless of where the truth lies, the perception often overshadowed the work taking place across the health service. Politics dominated headlines while waiting lists remained high, workforce pressures intensified and demand continued to rise. A return would offer an opportunity to change that narrative. Rather than defining his legacy through Westminster politics, Streeting could define it through NHS delivery.

Timing may prove to be everything. By the end of this year, the merger between the Department of Health and Social Care and NHS England is expected to be complete, creating one of the most significant changes to health governance in more than a decade. The intention is straightforward. Reduce duplication, improve accountability and bring decision making closer together. The execution, however, will be anything but simple. Structural reform has never been the NHS's biggest challenge. Delivering consistent operational improvement has.

Whoever occupies Richmond House next will inherit an NHS facing extraordinary pressure. Demand continues to rise faster than funding. Workforce shortages persist across clinical and non clinical professions. Capital investment has lagged behind international competitors for years. Productivity remains under intense scrutiny. Public expectations have never been higher, yet financial headroom has never been tighter. These are not problems that can be solved through another White Paper or another rebranding exercise. They require disciplined leadership and relentless execution.

Perhaps the greatest opportunity lies beyond organisational charts. The next NHS should not simply be measured by how many patients pass through hospitals, but by how many avoid needing them altogether. Artificial intelligence, remote monitoring, genomics, predictive analytics and personalised medicine are no longer concepts for the future. They are becoming the operating model of modern healthcare. The United Kingdom possesses world class science, globally respected clinicians and one of the richest health datasets anywhere in the world. The challenge has never been innovation. The challenge has been adoption at scale.

Industry will also be watching closely. Pharmaceutical companies, biotechnology firms, medical technology innovators and investors all value one thing above almost everything else: certainty. Frequent ministerial changes inevitably slow decision making, delay procurement and create uncertainty around long term policy. Stability at the top of the Department creates confidence throughout the system. That confidence ultimately influences research investment, clinical trials, commercial partnerships and the pace at which new technologies reach NHS patients.

There is another reason continuity matters. Successive governments have launched ambitious strategies for the NHS, many of which contained sensible ideas. Too often those strategies have been abandoned before they had the opportunity to succeed. Healthcare transformation rarely happens within a single Parliamentary term. It requires patience, consistency and political discipline. The temptation for every incoming minister is to announce a new vision. The more difficult task is finishing the work that has already begun.

Should Wes Streeting return, expectations will be significantly higher than during his first tenure. He would no longer have the benefit of novelty. He would inherit reforms already in motion, a newly integrated health leadership structure and an NHS expecting delivery rather than aspiration. The political honeymoon would be brief. Results would be expected almost immediately.

Ultimately, history is unlikely to remember another Health Secretary for speeches delivered at Party Conference or interviews given on Sunday morning television. It will remember whether patients waited less, whether staff stayed longer, whether innovation reached the frontline faster and whether taxpayers received better value for every pound invested. If the speculation proves correct, Wes Streeting will not simply be returning to one of the most demanding jobs in Government. He will be returning with an opportunity to demonstrate that his first term was preparation and that his second is where lasting reform begins.